CAPNIA

About:

CAPNIA employs its proprietary medical gas delivery system to develop therapeutic products for chronic diseases.

Top Investors: National Institutes of Health, Vivo Capital, Asset Management Ventures (AMV), Teknoinvest

Description:

CAPNIA is a private company developing novel therapeutic products using its proprietary medical gas delivery system. We are targeting a number of chronic diseases treatable with topical application of well understood, safe and effective gas compounds. Our first product is entering Phase IIb clinical trials for the treatment of acute migraines and related symptoms. 28 million Americans and over 240 million people worldwide suffer from this debilitating condition.

Total Funding Amount:

$49.6M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)capnia.com

Founders:

Julia S. Rasor

Number of Employees:

11-50

Last Funding Date:

2016-07-05

IPO Status:

Delisted

Industries: